- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Axial spondyloarthritis (axSpA) is a form of arthritis. It usually causes pain and swelling in the spine and the joints that connect the lower part of the spine to the pelvis (sacroiliac joint). Other joints may also be affected. It is a systemic disease, which means that it can affect other parts of the body and organs.
Showing 1–12 of 14 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
50 mg/mL |
– |
2 mg |
-80°C |
2021.12 |
304,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
2023.10 |
304,00 € |
||
TNF alpha |
Antibody Fab'fragment |
Cimzia® |
200 mg/mL |
– |
8 mg |
-80 °C |
2022.09 |
274,00 € |
||
TNF alpha |
Antibody Fab'fragment |
Cimzia® |
200 mg/mL |
– |
8 mg |
-80 °C |
2025.03 |
274,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
6 mg |
-80°C |
2024.01 |
259,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Benepali® |
50 mg/mL |
– |
4 mg |
-80°C |
2023.11 |
272,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
4 mg |
-80°C |
2019.02 |
234,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.04 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.06 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
4 mg |
-80°C |
2019.12 |
234,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.10 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2020.04 |
197,00 € |
||
IL-17A , IL-17A/F |
Monoclonal Antibody |
Taltz® |
80 mg/mL |
– |
4 mg |
-80 °C |
2023.08 |
550,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany